logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Global health education in Germany: an analysis of current capacity, needs and barriers

Kaffes I, Moser F, Pham M, Oetjen A, Fehling M
2016-11-25 • BMC Medical Education
2016-11-25 • BMC Medical Education
BACKGROUND
In times of increasing global challenges to health, it is crucial to create a workforce capable of tackling these complex issues. Even though a lack of GHE in Germany is p...
Journal Article
|
Research

embCAB Sequence Variation Among Ethambutol-Resistant Mycobacterium Tuberculosis Isolates Without embB306 Mutation

Plinke C, Cox HS, Zarkua N, Karimovich HA, Braker K,  et al.
2010-07-01 • Journal of Antimicrobial Chemotherapy
2010-07-01 • Journal of Antimicrobial Chemotherapy
Mechanisms of resistance to ethambutol in Mycobacterium tuberculosis remain inadequately described. Although there is mounting evidence that mutations of codon 306 in embB play a key rol...
Journal Article
|
Research

Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis [Review article]

Cox HS, Ford NP
2012-02-08 • International Journal of Tuberculosis and Lung Disease
2012-02-08 • International Journal of Tuberculosis and Lung Disease
BACKGROUND: Current treatment for drug-resistant tuberculosis (DR-TB) is inadequate, and outcomes are significantly poorer than for drug-susceptible TB, particularly for patients previou...
Journal Article
|
Research

Treatment Outcomes of Treatment-Naïve Hepatitis C Patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts

Davies A, Singh K, du Cros PAK, Mills EJ, Cooke GS,  et al.
2013-02-05 • PLOS One
2013-02-05 • PLOS One
Co-infection with Hepatitis C (HCV) and HIV is common and HIV accelerates hepatic disease progression due to HCV. However, access to HCV treatment is limited and success rates are genera...